ilyang pharmaceutical 007570 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 007570 Date
Period 3 months 100-m won
2017.12 2018.12 2019.12 Average 2019.06 2019.09 2019.12 2020.03 2020.06 2020.09
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 2,698 3,000 3,246 2,981 772 898 806 716 711 706 798
O-profit 244 167 325 245 78 89 61 68 67 67 74
N-income 129 33 196 119 34 63 26 53 77 111 44
O-rate 9.0 5.6 10.0 8.2 10.1 9.9 7.6 9.5 9.5 9.4 9.3
N-rate 4.8 1.1 6.0 4.0 4.4 7.0 3.2 7.4 10.8 15.7 5.5
ROE 6.1 1.6 8.8 5.5 6.2 8.6 6.5 7.6 8.4 9.3 7.2
Debt-ratio 106.8 106.0 96.4 103.1 100.3 96.8 96.4 93.5 89.6 85.7 96.8
Quick-ratio 55.3 60.1 64.6 60.0 60.6 68.4 64.6 60.7 64.9 70.4 63.6
reserve-ratio 192.0 184.4 203.9 193.4 196.9 204.5 203.9 203.9 206.8 209.9 202.3
EPS 660 169 1,004 611 174 323 133 271 392 566 225
BPS 10,803 10,747 11,403 10,984 11,315 11,638 11,403 11,653 11,888 12,126 11,502
Dividends 0 0 120 40
2020-05-29
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ 3 %
High mid ~ -10 %
Mid ~ -23 %
Low mid ~ -36 %
Low price ~ -49 %
Indication price Range Current stock price Company score
46,365 W 46,365 W 39,710 W
39,710 W 39,710 W 33,054 W Evaluation
53,021 W 53,021 W~ 46,365 W
51,300 W
44.033,054 W 33,054 W 26,399 W
High price
Normal
26,399 W 26,399 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Pharmaceutical 79 43 3,119 1,033
26,399원
33,054원
39,710원
46,365원
53,021원
High price 51,300원
-49%
-36%
-23%
-10%
3.4%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
10.%
0W
10,000W
20,000W
30,000W
40,000W
50,000W
60,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
ilyang pharmaceutical
Gap
ilyang pharmaceutical

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 007570 Date
Period
Gap
(Indication /
stock)
Color
2020-05-29
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
51,300 W High price 61.4 Normal 3,500,000 W
Suggested Purchase
Amount 1,364,183 W
Number of stocks
purchased 27
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 53,021 W 53,021 W~ ~ 46,365 W 3 % -45,762 W -1
High mid 46,365 W 46,365 W ~ 39,710 W -10 % 131,223 W 3
Mid 39,710 W 39,710 W ~ 33,054 W -23 % 308,208 W 8
Low mid 33,054 W 33,054 W ~ 26,399 W -36 % 485,193 W 15
low price 26,399 W 26,399 W ~ 0 W -49 % 662,178 W 25
Stock price rise
probability score
A Sector 48.2 52.7 43.0 51.6 50.8 48.2
61.4B Sector 29.6 41.7 54.2 51.6 23.3 32.1
Total average
2019.12.30 2020.01.31 2020.02.28 2020.03.27 2020.04.27 2020.05.28
38.9 47.2 48.6 24.6 37.1 40.1
34 % 8 %
2020.01.31 2020.02.28 2020.03.27 2020.04.27 2020.05.28
Total of
increase rate
Total score
A Sector 9 % -23 % 17 % -2 % -5 %
-7 % 49.7B Sector 29 % 23 % -5 % -121 % 27 %
Total average 18 % 3 % -98 %
48
53
43
52 51 48
30
42
54 52
23
32
39
47 49
25
37
40
0
10
20
30
40
50
60
2019.12.30 2020.01.31 2020.02.28 2020.03.27 2020.04.27 2020.05.28
Stock price rise probability score
A sector
B sector
Total average
9%
-23%
17%
-2% -5%
29% 23%
-5%
-121%
27%
18%
3%
-98%
34%
8%
-150%
-100%
-50%
0%
50%
2020.01.31 2020.02.28 2020.03.27 2020.04.27 2020.05.28
Increase rate of stock price rise
A sector
B sector
Total average
ilyang pharmaceutical

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report